summary
Current and future demands of viral vectors for the development of successful pre-clinical and clinical studies in human gene therapy and possible commercialization of gene therapy products require well-established large-scale production processes. One of the most promising vectors for human gene therapy is recombinant adeno-associated virus vectors (rAAVs). Some of the attractive features of rAAV are broad tissue tropism, low immunogenicity, ability to transduce both mitotic and post-mitotic cells, and long-term gene expression in non-dividing cells. Recently, we developed a novel technology for the production of these vectors exploiting baculovirus expression vectors (BEV) in insect cell cultures. Initially developed in small, shake flask format, this process has been successfully scaled to larger volumes. In an effort to standardize rAAV production in stirred tank bioreactors, we characterized the culture conditions to derive a set of parameters correlated with high rAAV yields. Measuring capacitance and dielectric spectroscopy with a permittivity probe enabled us to determine optimal times of infection and harvest. Consistent yields of rAAV, 2 × 10\(^{13}\) DNase-resistant vector genomes (vg) [1 × 10\(^{12}\) transducing units (tu)] per liter of cell culture were obtained in bioreactors with working volumes ranging from 10 to 40 l. This represents significant progress toward establishing a robust large-scale process at industry level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Herzog, R. W. (2004) AAV-mediated gene transfer to skeletal muscle. Methods Mol. Biol. 246, 179–194.
Kessler, P. D., Dubielzig, R., Grimm, D., and Kleinschmidt, J. A. (1996) Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U. S. A. 93, 14082–14087.
H., Huang, Y., Takagwa, J., Barcena, A., Rakawa-Hoyt, J., Grossman, W., and Kan, Y. W. (2006) AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect. Gene Ther. [Advanced online publication].
Muller, O. J., Leuchs, B., Pleger, S. T., Grimm, D., Franz, W. M., Katus, H. A., and Kleinschmidt, J. A. (2006) Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardivasc. Res. 1, 70–78.
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B. B., Meuse, L., Cohen, L. K., Thompson, A. R., and Kay, M. A. (1997) Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16, 270–276.
Manno, C. S., Arruda, V. R., Pierce, G. F., Glader, B., Ragni, M., Rasko, J., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., Dake, M., Kaye, R., Razavi, M., Zajko, A., Zehnder, J., Nakai, H., Chew, A., Leonard, D., Wright, J. F., Lessard, R. R., Sommer, J. M., Tigges, M., Sabatino, D., Luk, A., Jiang, H., Mingozzi, F., Couto, L., Ertl, H. C., High, K. A., and Kay, M. A. (2006) Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342–347.
Kaplitt, M. G., Leone, P., Samulski, R. J., Xiao, X., Pfaff, D. W., O’Malley, K. L., and During, M. J. (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain . Nat. Genet. 8, 148–154.
Xia, H., Mao, Q., Eliason, S. L., Harper, S. Q., Martins, I. H., Orr, H. T., Paulson, H. L., Yang, L., Kotin, R. M., and Davidson, B. L. (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat. Med. 10, 816–820.
Flannery, J. G., Zolotukhin, S., Vaquero, M. I., LaVail, M. M., Muzyczka, N., and Hauswirth, W. W. (1997) Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U. S. A. 94, 6916–6921.
Auricchio, A., and Rolling, F. (2005) Adeno-associated viral vectors for retinal gene transfer and treatment of retinal diseases. -Curr. Gene Ther. 5, 339–348.
Halbert, C. L., Allen, J. M., and Miller, A. D. (2002) Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat. Biotechnol. 20, 697–701.
Handa, A., Muramatsu, S., Qiu, J., Mizukami, H., and Brown, K. E. (2000) Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J. Gen. Virol. 81, 2077–2084.
Carter, B. J. (2005) Adeno-associated virus vectors in clinical trials. Hum. Gene Ther. 16, 541–550.
Fukuchi, K. I., Tahara, K., Kim. H., D., Maxwell, J. A., Lewis, T. L., Ccavitti-Loper, M. A., Kim, H., Ponnazhagan, S., and Lalonde, R. (2006) Anti-Abeta single chain antibody delivery via adeno-associated virus for treatment of Alzheimer’s disease. Neurobiol Dis. [Advanced online publication].
Lucas, A., Kremer, E. J., Hemmi, S., Luis, J., Vignon, F., and Lazennec, G. (2003) Comparative transductions of breast cancer cells by three DNA viruses. Biochem. Biophys. Res. Commun. 4, 1011–1016.
De, B. P., Heguy, A., Hackett, N. R., Ferris, B., Leopold, P. R., Lee, J., Pierre, L., Gao, G., Wilson, J. M., and Crystal, R. G. (2006) High levels of persistent expression of alpha 1-antitrypsin mediated by the nonhuman primate serotype rh.10 adeno-associated virus despite preexisting immunity to common human adeno-associated viruses. Mol. Ther. 1, 67–76.
Grieger, J. C. and Samulski, R. J. (2005) Adeno-associated virus as a gene therapy vector: development, production and clinical applications. Adv. Biochem. Eng. Biotechnol. 99, 119–145.
Athanasopoulos, T. Graham, I. R., Foster, H., and Dickson, G. (2004) Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). Gene Ther. 1S, 109–121.
Urabe, M., Ding, C., and Kotin, R. M. (2002) Insect cells as a factory to produce adeno-associated virus type 2 vectors. Hum. Gene Ther. 13, 1935–1943.
Power, J., Greenfield, P. F., Nielsen, L., and Reid, S. (1992) Modelling the growth and protein production by insect cells following infection by a recombinant baculovirus in suspension culture. Cytotechnology 9, 149–155.
B’edard, C., Jolicoeur, M., Jardin, B., Tom, R., Perret, S., and Kamen, A. (1994) Insect cell density in bioreactor cultures can be estimated from on-line measurements of optical density. Biotechnol Tech. 8, 605–610.
Akhnoukh, R., Gerlinde K., and Schugerl, K. (1996) On-line monitoring and control of the cultivation of Spodoptera frugiperda Sf9 insect cells and [beta]-galactosidase production by Autographa californica virus vector. Enzyme Microb. Tech. 18, 220–228.
Kamen, A. A., B’edard, C., Tom, R., Perret, S., and Jardin, B. (1996) On-line monitoring of respiration in recombinant-baculovirus-infected and uninfected insect cell bioreactor cultures. Biotechnol. Bioeng. 50, 36–48.
Palomares, L. A., and Ramirez, O. T. (1996) The effect of dissolved oxygen tension and the utility of oxygen uptake rate in insect cell culture. Cytotechnology 22, 225–237.
Zeiser, A., Elias, C. B., Voyer, R., Jardin, B., and Kamen, A. A. (2000) On-line monitoring of physiological parameters of insect cell cultures during the growth and infection process Biotechnol. Prog. 16, 803–808.
Zeiser, A., Bedard, C., Voyer, R., Jardin, B., Tom, R., and Kamen, A. A. (1999) On-line monitoring of the progress of infection in Sf-9 insect cell cultures using relative permittivity measurements. Biotechnol. Bioeng. 63, 122–126.
Licari, P., and Bailey, J. E. (1992) Modeling the population dynamics of baculovirus-infected insect cells: Optimizing infection strategies for enhanced recombinant protein yields. Biotechnol. Bioeng. 39, 432–441.
A., Esteban, G., and Kotin, R. M. (2007) Dielectric Spectroscopy monitoring for optimum harvest time determination during large-scale production of recombinant adeno-associated vectors. Appl. microbial. Biotechnol. In press. doi: 10.1007/s00253-007-1030-9.
Acknowledgments
The authors thank Joseph Shiloach and Loc Trinh for providing the facilities for 40 l production and Geoffrey Esteban for the spectroscopy analysis.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Negrete, A., Kotin, R.M. (2008). Large-Scale Production of Recombinant Adeno-Associated Viral Vectors. In: Gene Therapy Protocols. Methods in Molecular Biology™, vol 433. Humana Press. https://doi.org/10.1007/978-1-59745-237-3_5
Download citation
DOI: https://doi.org/10.1007/978-1-59745-237-3_5
Publisher Name: Humana Press
Print ISBN: 978-1-58829-903-1
Online ISBN: 978-1-59745-237-3
eBook Packages: Springer Protocols